The anti-viral remedy has proven to stop extreme sickness and loss of life in 85 per cent of instances handled early.
The world’s latest anti-viral remedy for Covid-19, Sotrovimab, is now obtainable for early remedy of sure classes Covid-19 sufferers within the UAE following a landmark settlement between the Abu Dhabi Division of Well being, the nation’s main group buying group (GPO) Rafed, and world revolutionary biopharmaceutical firm GlaxoSmithKline (GSK). With the arrival of the primary cargo in Abu Dhabi airport, Abu Dhabi turn into the primary metropolis globally to obtain this drug.
Sotrovimab is a monoclonal antibody remedy delivered by means of intravenous remedy. Sotrovimab can be utilized to deal with adults and kids above the age of 12 who meet sure standards and are prone to progressing to extreme Covid-19, as per protocols which have been developed by the Nationwide Scientific Committee. Research have proven the drugs to stop hospitalization and loss of life in 85 per cent of early chosen remedy instances and might work on all identified variations to this point, a press release issued on Wednesday stated.
UAE approves extremely efficient Covid remedy
Following USA Meals and Drug Company Emergency use authorization approval, the UAE Ministry of Well being and Prevention (MoHAP) issued its endorsement of the brand new GSK medication following a nationwide evaluation. Abu Dhabi Division of Well being & Rafed executed its settlement with the producer to make sure deliveries as early as June and July, enabling sufferers within the UAE to be among the many first on this planet to entry the brand new remedy.
The Nationwide Scientific Committee in MoHAP & Abu Dhabi Division of Well being have labored on the remedy protocols that may information medical doctors in defining in danger sufferers and guaranteeing that they’ve entry to Sotrovimab in line with their threat profile and eligibility standards.
Abu Dhabi-based Rafed will facilitate the procurement, storage and distribution of Sotrovimab by way of the Rafed Distribution Middle – the Area’s largest specialised cold-storage facility. The Middle is a part of the Hope Consortium, and is a milestone collaboration by healthcare, logistics and provide chain entities designed to facilitate the continued evolution of Abu Dhabi’s medical and life science providing to fight the pandemic, nationally and internationally
HE Dr. Jamal Mohamed Kaabi, Undersecretary for the Abu Dhabi Division of Well being, stated: “Abu Dhabi continues in its efforts to take care of its primary metropolis place globally when it comes to resilience and security in Covid-19 occasions. This medication is on the forefront of pharmaceutical development and is a strong instrument in our battle to finish this pandemic.
“We look ahead to implement the eligibility standards for emergency use of Sotrovimab as a part of Abu Dhabi’s dedication to guide an all-encompassing Covid -19 response in prevention, remedy and care.”
Rashed Al Qubaisi, CEO of Rafed stated: “Sotrovimab represents a large breakthrough within the battle in opposition to COVID-19.”
Because the Division of Well being – Abu Dhabi finalises a coherent framework to find out eligibility for Sotrovimab remedy, Etihad Cargo, the cargo and logistics arm of the Etihad Aviation Group and Hope Consortium, have transported the primary batch of Sotrovimab into the UAE using its IATA CEIV-certified PharmaLife product.
Tony Douglas, Group Chief Government Officer, Etihad Aviation Group, stated: “This achievement additional elevates Abu Dhabi’s main place within the battle in opposition to Covid-19, and firmly illustrates the mixed capabilities of these entities on the forefront of the capital’s mission.
After receiving constructive scientific opinion by the European Medicines Company’s (EMA) Committee for Human Medicinal Merchandise – GSK had submitted an Emergency Use Authorization (EUA) software to the US Meals and Drug Administration and the UAE Ministry of Well being and Prevention and received approval from each.
“We’ve got been working very intently with the Division of Well being and Rafed for the reason that interim outcomes of the medical trials with Sotrovimab have been obtainable” stated Gizem Akalin, Managing Director and Vice President, GSK Gulf. “The DOH and Rafed have been agile and keen about accelerating affected person entry to promising new remedies to confront Covid-19”.